| Pavlovsky, Astrid |
NCT03964480: Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma. |
|
|
| Recruiting | N/A | 1000 | Europe, US, RoW | | Associazione Angela Serra per la ricerca sul cancro | Peripheral T-Cell Lymphoma | 01/23 | 07/25 | | |
NCT04776265: RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT |
|
|
| Recruiting | N/A | 100 | RoW | Evaluation of therapeutical approach after ASCT | Grupo Argentino de Tratamiento de la Leucemia Aguda, Takeda | Hodgkin Lymphoma, Adult, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma | 03/24 | 04/24 | | |
NCT05078840: PET Adapted Treatment of Patients With Limited Stage DLBCL and no Risk Factors |
|
|
| Recruiting | N/A | 75 | RoW | Evaluation of first line treatment in patients with stage I and II LBCL | Grupo Argentino de Tratamiento de la Leucemia Aguda | Lymphoma, Non-Hodgkin's, Adult | 06/24 | 06/25 | | |
| Fiad, Lorena |
NCT04776265: RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT |
|
|
| Recruiting | N/A | 100 | RoW | Evaluation of therapeutical approach after ASCT | Grupo Argentino de Tratamiento de la Leucemia Aguda, Takeda | Hodgkin Lymphoma, Adult, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma | 03/24 | 04/24 | | |
NCT05078840: PET Adapted Treatment of Patients With Limited Stage DLBCL and no Risk Factors |
|
|
| Recruiting | N/A | 75 | RoW | Evaluation of first line treatment in patients with stage I and II LBCL | Grupo Argentino de Tratamiento de la Leucemia Aguda | Lymphoma, Non-Hodgkin's, Adult | 06/24 | 06/25 | | |
| Aranguren, Florencia Negri |
NCT04776265: RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT |
|
|
| Recruiting | N/A | 100 | RoW | Evaluation of therapeutical approach after ASCT | Grupo Argentino de Tratamiento de la Leucemia Aguda, Takeda | Hodgkin Lymphoma, Adult, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma | 03/24 | 04/24 | | |
NCT05078840: PET Adapted Treatment of Patients With Limited Stage DLBCL and no Risk Factors |
|
|
| Recruiting | N/A | 75 | RoW | Evaluation of first line treatment in patients with stage I and II LBCL | Grupo Argentino de Tratamiento de la Leucemia Aguda | Lymphoma, Non-Hodgkin's, Adult | 06/24 | 06/25 | | |
NCT05127148: RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL |
|
|
| Recruiting | N/A | 100 | RoW | Evaluation of survival and toxicities in AYA Ph-negative ALL patients treating in first line depending on risk category. | Grupo Argentino de Tratamiento de la Leucemia Aguda | Acute Lymphoblastic Leukemia, Adult | 03/26 | 12/26 | | |
NCT04897490: RWE of 1st Line Treatment With ATO/ATRA for Adult APL |
|
|
| Recruiting | N/A | 50 | RoW | Evaluation of first line treatment with ATO/ATRA outcome | Grupo Argentino de Tratamiento de la Leucemia Aguda | Promyelocytic Leukemia, Adult Acute | 07/26 | 12/26 | | |
| Osorio, MarÃa José Mela |
NCT04897490: RWE of 1st Line Treatment With ATO/ATRA for Adult APL |
|
|
| Recruiting | N/A | 50 | RoW | Evaluation of first line treatment with ATO/ATRA outcome | Grupo Argentino de Tratamiento de la Leucemia Aguda | Promyelocytic Leukemia, Adult Acute | 07/26 | 12/26 | | |
| Fernández, Isolda |
NCT05127148: RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL |
|
|
| Recruiting | N/A | 100 | RoW | Evaluation of survival and toxicities in AYA Ph-negative ALL patients treating in first line depending on risk category. | Grupo Argentino de Tratamiento de la Leucemia Aguda | Acute Lymphoblastic Leukemia, Adult | 03/26 | 12/26 | | |
NCT04897490: RWE of 1st Line Treatment With ATO/ATRA for Adult APL |
|
|
| Recruiting | N/A | 50 | RoW | Evaluation of first line treatment with ATO/ATRA outcome | Grupo Argentino de Tratamiento de la Leucemia Aguda | Promyelocytic Leukemia, Adult Acute | 07/26 | 12/26 | | |
| Sackmann, Federico |
NCT04897490: RWE of 1st Line Treatment With ATO/ATRA for Adult APL |
|
|
| Recruiting | N/A | 50 | RoW | Evaluation of first line treatment with ATO/ATRA outcome | Grupo Argentino de Tratamiento de la Leucemia Aguda | Promyelocytic Leukemia, Adult Acute | 07/26 | 12/26 | | |
| Fernandez, Isolda |
NCT05127798: RWE of 1st Line Treatment in Adults With AML From 18 to 70 Years Old. |
|
|
| Recruiting | N/A | 50 | RoW | Evaluation of first line treatment with intensive treatment outcome in adult patients with AML. | Grupo Argentino de Tratamiento de la Leucemia Aguda | Acute Myeloid Leukemia, Adult | 03/24 | 12/24 | | |
| Moirano, Maria |
NCT05127148: RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL |
|
|
| Recruiting | N/A | 100 | RoW | Evaluation of survival and toxicities in AYA Ph-negative ALL patients treating in first line depending on risk category. | Grupo Argentino de Tratamiento de la Leucemia Aguda | Acute Lymphoblastic Leukemia, Adult | 03/26 | 12/26 | | |
| Ferrari, Luciana |
NCT05127148: RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL |
|
|
| Recruiting | N/A | 100 | RoW | Evaluation of survival and toxicities in AYA Ph-negative ALL patients treating in first line depending on risk category. | Grupo Argentino de Tratamiento de la Leucemia Aguda | Acute Lymphoblastic Leukemia, Adult | 03/26 | 12/26 | | |
| Cazap, Nicolás |
NCT04897490: RWE of 1st Line Treatment With ATO/ATRA for Adult APL |
|
|
| Recruiting | N/A | 50 | RoW | Evaluation of first line treatment with ATO/ATRA outcome | Grupo Argentino de Tratamiento de la Leucemia Aguda | Promyelocytic Leukemia, Adult Acute | 07/26 | 12/26 | | |
